BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galimberti F, McBride J, Cronin M, Li Y, Fox J, Abrouk M, Herbst A, Kirsner RS. Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19. Clin Dermatol 2020;38:775-80. [PMID: 32419721 DOI: 10.1016/j.clindermatol.2020.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lim ZV, Lim YL. Impact of COVID-19 on Clinical Operations and Management of Patients in a Singapore Immunodermatology Unit during the 'Circuit-Breaker' Period and Beyond. Ann Acad Med Singap 2020;49:919-21. [PMID: 33381789 [PMID: 33381789 DOI: 10.47102/annals-acadmedsg.2020311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Scharringa S, Hoffman T, van Kessel DA, Rijkers GT. Vaccination and their importance for lung transplant recipients in a COVID-19 world. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34328054 DOI: 10.1080/17512433.2021.1961577] [Reference Citation Analysis]
3 Bhargava S, Negbenebor N, Sadoughifar R, Ahmad S, Kroumpouzos G. Global impact on dermatology practice due to the COVID-19 pandemic. Clin Dermatol 2021;39:479-87. [PMID: 34518007 DOI: 10.1016/j.clindermatol.2021.01.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Jafri ZA, Walia S, Ivanic MG, Wu JJ. Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris. J Dermatolog Treat 2021;:1-3. [PMID: 33375865 DOI: 10.1080/09546634.2020.1870648] [Reference Citation Analysis]
5 Sinha R, Anand S, Singh D, Tripathi S, Shukla P, Singh S, Srivastava P. Bioprocessing strategies for microbial production and purification of immunosuppressants: an insight for process intensification. Chemical Engineering and Processing - Process Intensification 2022. [DOI: 10.1016/j.cep.2022.108797] [Reference Citation Analysis]
6 Martínez-Botía P, Bernardo Á, Acebes-Huerta A, Caro A, Leoz B, Martínez-Carballeira D, Palomo-Antequera C, Soto I, Gutiérrez L. Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns. J Clin Med 2021;10:1073. [PMID: 33806709 DOI: 10.3390/jcm10051073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Qu C, Fuhler GM, Pan Y. Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Int J Mol Sci 2021;22:5672. [PMID: 34073529 DOI: 10.3390/ijms22115672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]